Heping Lei

673 total citations
20 papers, 514 citations indexed

About

Heping Lei is a scholar working on Molecular Biology, Pharmacology and Complementary and alternative medicine. According to data from OpenAlex, Heping Lei has authored 20 papers receiving a total of 514 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Pharmacology and 5 papers in Complementary and alternative medicine. Recurrent topics in Heping Lei's work include High-Temperature Coating Behaviors (3 papers), Pharmacogenetics and Drug Metabolism (3 papers) and Ginkgo biloba and Cashew Applications (3 papers). Heping Lei is often cited by papers focused on High-Temperature Coating Behaviors (3 papers), Pharmacogenetics and Drug Metabolism (3 papers) and Ginkgo biloba and Cashew Applications (3 papers). Heping Lei collaborates with scholars based in China, Macao and Australia. Heping Lei's co-authors include Lan Fan, Dongli Hu, Yao Chen, Zhi‐Rong Tan, Hong‐Hao Zhou, Hong‐Hao Zhou, Dong Guo, Dan Wang, Wang Guo and Zhi Li and has published in prestigious journals such as SHILAP Revista de lepidopterología, Clinical Pharmacokinetics and Pharmacological Research.

In The Last Decade

Heping Lei

19 papers receiving 500 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Heping Lei China 13 174 114 111 89 87 20 514
Zhaoyi Huang China 14 118 0.7× 221 1.9× 277 2.5× 78 0.9× 192 2.2× 19 781
Shenglan Tan China 13 59 0.3× 65 0.6× 196 1.8× 53 0.6× 44 0.5× 29 444
Satoru Mineshita Japan 14 197 1.1× 53 0.5× 174 1.6× 58 0.7× 171 2.0× 61 705
Zhu Zhou United States 13 105 0.6× 68 0.6× 106 1.0× 83 0.9× 70 0.8× 34 513
Fengwen Yang China 15 75 0.4× 63 0.6× 105 0.9× 40 0.4× 41 0.5× 68 635
Wenke Zheng China 13 139 0.8× 61 0.5× 100 0.9× 42 0.5× 37 0.4× 48 488
Pajaree Chariyavilaskul Thailand 12 60 0.3× 35 0.3× 66 0.6× 37 0.4× 63 0.7× 53 424
Hiromitsu Imai Japan 13 164 0.9× 30 0.3× 109 1.0× 49 0.6× 87 1.0× 32 541
Sanlan Wu China 14 69 0.4× 194 1.7× 139 1.3× 89 1.0× 51 0.6× 37 538
Ruijuan Liu China 12 75 0.4× 78 0.7× 151 1.4× 49 0.6× 70 0.8× 37 503

Countries citing papers authored by Heping Lei

Since Specialization
Citations

This map shows the geographic impact of Heping Lei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heping Lei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heping Lei more than expected).

Fields of papers citing papers by Heping Lei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heping Lei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heping Lei. The network helps show where Heping Lei may publish in the future.

Co-authorship network of co-authors of Heping Lei

This figure shows the co-authorship network connecting the top 25 collaborators of Heping Lei. A scholar is included among the top collaborators of Heping Lei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heping Lei. Heping Lei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Lei, Heping, et al.. (2024). Optimization of Process Parameters and Microstructure of CoCrFeNiTiAl High-Performance High-Entropy Alloy Coating. Metals. 14(12). 1384–1384. 5 indexed citations
4.
Liu, Yingjian, Huafeng He, Min Qin, et al.. (2024). Characterizing the metabolic divide: distinctive metabolites differentiating CAD-T2DM from CAD patients. Cardiovascular Diabetology. 23(1). 14–14. 4 indexed citations
5.
Hu, Wei, Qian Ding, Jianghong Cai, et al.. (2022). Update of Indoles: Promising molecules for ameliorating metabolic diseases. Biomedicine & Pharmacotherapy. 150. 112957–112957. 29 indexed citations
6.
Lei, Heping, Min Qin, Hongmin Wu, et al.. (2021). UGT1A1 rs4148323 A Allele is Associated With Increased 2-Hydroxy Atorvastatin Formation and Higher Death Risk in Chinese Patients With Coronary Artery Disease. Frontiers in Pharmacology. 12. 586973–586973. 5 indexed citations
7.
Hu, Wei, Meng Li, Wu‐Yi Sun, et al.. (2021). Hirsutine ameliorates hepatic and cardiac insulin resistance in high-fat diet-induced diabetic mice and in vitro models. Pharmacological Research. 177. 105917–105917. 37 indexed citations
8.
Qin, Min, Qian Zhu, Weihua Lai, et al.. (2020). Insights into the prognosis of lipidomic dysregulation for death risk in patients with coronary artery disease. SHILAP Revista de lepidopterología. 10(5). e189–e189. 20 indexed citations
9.
Lei, Heping, Hongmin Wu, Jiyan Chen, et al.. (2018). Plasma miR-142 predicts major adverse cardiovascular events as an intermediate biomarker of dual antiplatelet therapy. Acta Pharmacologica Sinica. 40(2). 208–215. 28 indexed citations
10.
Bai, Xue, Heping Lei, Hong Wu, et al.. (2018). High Plasma Exposure of Statins Associated With Increased Risk of Contrast-Induced Acute Kidney Injury in Chinese Patients With Coronary Artery Disease. Frontiers in Pharmacology. 9. 427–427. 8 indexed citations
11.
Lin, Yubi, Zili Liao, Ruiling Feng, et al.. (2017). Whole exome sequencing identified a pathogenic mutation in RYR2 in a Chinese family with unexplained sudden death. Journal of Electrocardiology. 51(2). 309–315. 8 indexed citations
12.
13.
Zheng, Zhijie, Xipei Wang, Lan Tang, et al.. (2017). Simultaneous determination of atorvastatin and its metabolites in human plasma by UPLC-MS/MS. Analytical Methods. 9(6). 1038–1045. 12 indexed citations
14.
Lei, Heping, Hongmei Chen, Shilong Zhong, et al.. (2012). Association between polymorphisms of the renin–angiotensin system and coronary artery disease in Chinese patients with type 2 diabetes. Journal of the Renin-Angiotensin-Aldosterone System. 13(2). 305–313. 13 indexed citations
15.
Lei, Heping, Xuhua Yu, Hong‐Guang Xie, et al.. (2010). Effect of St. John’s wort supplementation on the pharmacokinetics of bupropion in healthy male Chinese volunteers. Xenobiotica. 40(4). 275–281. 22 indexed citations
16.
Lei, Heping, Wei Ji, Jian Lin, et al.. (2009). Effects ofGinkgo bilobaextract on the pharmacokinetics of bupropion in healthy volunteers. British Journal of Clinical Pharmacology. 68(2). 201–206. 27 indexed citations
17.
Fan, Lan, Guo Wang, Yao Chen, et al.. (2009). Effects of Ginkgo biloba Extract Ingestion on the Pharmacokinetics of Talinolol in Healthy Chinese Volunteers. Annals of Pharmacotherapy. 43(5). 944–949. 65 indexed citations
18.
Lei, Heping, Guo Wang, Liansheng Wang, et al.. (2009). Lack of Effect of Ginkgo biloba on Voriconazole Pharmacokinetics in Chinese Volunteers Identified as CYP2C19 Poor and Extensive Metabolizers. Annals of Pharmacotherapy. 43(4). 726–731. 34 indexed citations
19.
Guo, Wang, Heping Lei, Zhi Li, et al.. (2008). The CYP2C19 ultra-rapid metabolizer genotype influences the pharmacokinetics of voriconazole in healthy male volunteers. European Journal of Clinical Pharmacology. 65(3). 281–285. 137 indexed citations
20.
Fan, Lan, Jinchao Wang, Fen Jiang, et al.. (2008). Induction of cytochrome P450 2B6 activity by the herbal medicine baicalin as measured by bupropion hydroxylation. European Journal of Clinical Pharmacology. 65(4). 403–409. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhaoyi Huang Breakdown of academic impact, for papers by Shenglan Tan Breakdown of academic impact, for papers by Satoru Mineshita Breakdown of academic impact, for papers by Zhu Zhou Breakdown of academic impact, for papers by Fengwen Yang Breakdown of academic impact, for papers by Wenke Zheng Breakdown of academic impact, for papers by Pajaree Chariyavilaskul Breakdown of academic impact, for papers by Hiromitsu Imai Breakdown of academic impact, for papers by Sanlan Wu Breakdown of academic impact, for papers by Ruijuan Liu
Rankless by CCL
2026